US Patent Issued to Genentech on May 20 for "Treatment of breast cancer using combination therapies comprising GDC-9545 and a CDK4/6 inhibitor" (California Inventors)

ALEXANDRIA, Va., June 16 -- United States Patent no. 12,303,495, issued on May 20, was assigned to Genentech Inc. (South San Francisco, Calif.).

"Treatment of breast cancer using combination therapies comprising GDC-9545 and a CDK4/6 inhibitor" was invented by Jennifer O'Hara Lauchle (Larkspur, Calif.), Sandra Milan (Orinda, Calif.), Melanie Carol Smitt (Portola Valley, Calif.) and Marjorie C. Green (South San Francisco, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided herein are combination therapies comprising GDC-9545 and a CDK4/6 inhibitor for treating locally advanced breast cancer or metastatic breast cancer."

The patent was filed on Jan. 26, 2024, under Application No. 18/423,596.

*For...